Calla Lily Clinical Care and Merck Announce Strategic Collaboration to Advance Intravaginal Drug Delivery Platform

Core Insights - Calla Lily Clinical Care and Merck have formed a strategic collaboration to advance the development of Callavid®, a novel intravaginal drug delivery platform [1] - This partnership marks the first industry collaboration for the Callavid technology, indicating significant potential for market impact [1] - Callavid is designed as a leak-resistant medical device aimed at overcoming challenges in women's health [1]